• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性青少年骨质疏松症中的矿物质代谢与骨化三醇治疗

Mineral metabolism and calcitriol therapy in idiopathic juvenile osteoporosis.

作者信息

Saggese G, Bertelloni S, Baroncelli G I, Perri G, Calderazzi A

机构信息

Department of Pediatrics, University of Pisa, Italy.

出版信息

Am J Dis Child. 1991 Apr;145(4):457-62. doi: 10.1001/archpedi.1991.02160040119019.

DOI:10.1001/archpedi.1991.02160040119019
PMID:2012031
Abstract

Idiopathic juvenile osteoporosis is a rare cause of osteoporosis during childhood. We examined four children (three boys and one girl, ranging in age from 2.3 to 12.6 years) with idiopathic juvenile osteoporosis. All of these patients had normal serum calcium, ionized calcium, phosphate, magnesium, 25-hydroxyvitamin D, intact parathyroid hormone, and total and extractable calcitonin levels. 1,25-Dihydroxyvitamin D values were low in three patients and slightly decreased in one. Three children were treated with calcitriol (1,25-dihydroxycholecalciferol) (0.50 micrograms/d in two and 0.25 microgram/d in the other). The fourth patient was not treated because of parental refusal. Therapy reduced the fracture rate. Follow-up at 6 and 12 months showed a significant increase in bone mineralization, which reached normal values in two children after 12 months of treatment. No side effects of calcitriol therapy were observed. The untreated patient did not show an improvement of bone mineralization in the same time.

摘要

特发性青少年骨质疏松症是儿童期骨质疏松症的罕见病因。我们检查了4例特发性青少年骨质疏松症患儿(3例男孩和1例女孩,年龄在2.3至12.6岁之间)。所有这些患者的血清钙、离子钙、磷酸盐、镁、25-羟基维生素D、完整甲状旁腺激素以及总降钙素和可提取降钙素水平均正常。3例患者的1,25-二羟基维生素D值较低,1例略有下降。3例患儿接受了骨化三醇(1,25-二羟胆钙化醇)治疗(2例每日0.50微克,另1例每日0.25微克)。第四例患者因家长拒绝而未接受治疗。治疗降低了骨折发生率。6个月和12个月的随访显示骨矿化显著增加,2例患儿在治疗12个月后骨矿化达到正常水平。未观察到骨化三醇治疗的副作用。未治疗的患者在同一时期骨矿化未改善。

相似文献

1
Mineral metabolism and calcitriol therapy in idiopathic juvenile osteoporosis.特发性青少年骨质疏松症中的矿物质代谢与骨化三醇治疗
Am J Dis Child. 1991 Apr;145(4):457-62. doi: 10.1001/archpedi.1991.02160040119019.
2
Mineral homeostasis during lactation- relationship to serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone and calcitonin.哺乳期的矿物质稳态——与血清1,25 - 二羟维生素D、25 - 羟维生素D、甲状旁腺激素和降钙素的关系
Am J Clin Nutr. 1982 Sep;36(3):431-7. doi: 10.1093/ajcn/36.3.431.
3
Effect of calcitonin replacement therapy in idiopathic juvenile osteoporosis.降钙素替代疗法对特发性青少年骨质疏松症的影响。
Am J Dis Child. 1988 Nov;142(11):1237-9. doi: 10.1001/archpedi.1988.02150110115034.
4
Calcitriol deficiency in idiopathic juvenile osteoporosis.特发性青少年骨质疏松症中的骨化三醇缺乏
Am J Dis Child. 1982 Oct;136(10):914-7. doi: 10.1001/archpedi.1982.03970460044010.
5
Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.生长激素长期治疗对生长激素缺乏症儿童骨骼和矿物质代谢的影响。
J Pediatr. 1993 Jan;122(1):37-45. doi: 10.1016/s0022-3476(05)83484-5.
6
Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.降钙素与1,25 - 二羟维生素D3联合治疗女性骨质疏松症
Calcif Tissue Int. 1993 Jul;53(1):26-8. doi: 10.1007/BF01352011.
7
Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.雌激素与骨化三醇联合治疗预防年龄相关性骨质流失
J Clin Endocrinol Metab. 2001 Aug;86(8):3618-28. doi: 10.1210/jcem.86.8.7703.
8
[Calciotropic hormones in rheumatology].[风湿病学中的钙调节激素]
Ann Biol Clin (Paris). 1997 Jul-Aug;55(4):311-8.
9
[The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study].[1,25-二羟维生素D3对老年性骨质疏松症骨矿物质含量的影响——一项剂量探索性研究]
Nihon Naibunpi Gakkai Zasshi. 1989 Nov 20;65(11):1253-63. doi: 10.1507/endocrine1927.65.11_1253.
10
Serum vitamin D metabolites and bone mineralization in young children with chronic low to moderate lead exposure.慢性低至中度铅暴露幼儿的血清维生素D代谢物与骨矿化
Pediatrics. 1991 May;87(5):680-7.

引用本文的文献

1
Idiopathic juvenile osteoporosis: A case report and review of the literature.特发性青少年骨质疏松症:一例病例报告及文献综述
Int J Surg Case Rep. 2015;9:127-9. doi: 10.1016/j.ijscr.2015.02.043. Epub 2015 Feb 26.
2
The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.原发性骨质疏松症的不断扩大之谜:病因发病机制、诊断和治疗。
Ital J Pediatr. 2014 Jun 7;40:55. doi: 10.1186/1824-7288-40-55.
3
Bone mineral density deficits and fractures in survivors of childhood cancer.儿童癌症幸存者的骨矿物质密度不足和骨折。
Curr Osteoporos Rep. 2013 Dec;11(4):329-37. doi: 10.1007/s11914-013-0165-0.
4
Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.帕米膦酸盐治疗可刺激恢复阶段的开始,降低特发性青少年骨质疏松症患者的骨折发生率和骨骼畸形:与未治疗患者的比较。
J Bone Miner Metab. 2013 Sep;31(5):533-43. doi: 10.1007/s00774-013-0438-9. Epub 2013 Apr 3.
5
Calcium supplementation for improving bone mineral density in children.补充钙以提高儿童的骨密度。
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD005119. doi: 10.1002/14651858.CD005119.pub2.
6
Osteoporosis in children and adolescents: etiology and management.儿童和青少年骨质疏松症:病因与管理
Paediatr Drugs. 2005;7(5):295-323. doi: 10.2165/00148581-200507050-00003.
7
Intravenous pamidronate in juvenile osteoporosis.静脉注射帕米膦酸盐治疗青少年骨质疏松症。
Arch Dis Child. 2000 Aug;83(2):143-5. doi: 10.1136/adc.83.2.143.
8
Idiopathic juvenile osteoporosis: evidence of normal osteoblast function by 1,25-dihydroxyvitamin D3 stimulation test.特发性青少年骨质疏松症:1,25 - 二羟维生素D3刺激试验显示成骨细胞功能正常的证据。
Calcif Tissue Int. 1992 Jul;51(1):20-3. doi: 10.1007/BF00296211.